Diabetes Therapy
Recent findings illuminate research in diabetes therapy
Published in Obesity and Diabetes Week, July 18th, 2005
Study 1: Atorvastatin significantly reduced vascular events in high-risk patients with type 2 diabetes.
"Vascular complications are a major cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). The recently published Collaborative Atorvastatin Diabetes Study (CARDS) showed that atorvastatin (10 mg, once daily vs placebo) markedly reduces vascular events in this high-risk population. The participants (n=2,838) were fairly typical T2DM patients without cardiovascular disease and with at least one other risk factor: hypertension,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Pathology
Aerobic exercise helps find genetic regions linked to prediabetes - Diabetes Therapy
Barriers to diabetes education in urban patients presented - Diabetic Complications
Pioglitazone HCL significantly improves components of diabetic dyslipidemia - Diet and Nutrition
Statistics provide information on dietary factors in type 2 diabetes - Hypoglycemia
Low plasma glucose levels associated with lower gestational diabetes incidence - Amyotrophic Lateral Sclerosis
Phase II trial for ALS expected to begin after second quarter - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
